Scarica l'app Stockscreener
2.29
1.78%
0.04
Dopo l'orario di chiusura:
2.33
0.04
+1.75%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché AYTU Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.25
Aprire:
$2.28
Volume 24 ore:
103.32K
Relative Volume:
0.08
Capitalizzazione di mercato:
$20.56M
Reddito:
$93.76M
Utile/perdita netta:
$-13.68M
Rapporto P/E:
-0.8707
EPS:
-2.63
Flusso di cassa netto:
$8.77M
1 W Prestazione:
-5.76%
1M Prestazione:
+5.05%
6M Prestazione:
+65.94%
1 anno Prestazione:
-5.27%
Intervallo 1D:
$2.25
$2.3399
Intervallo di 1 settimana:
$2.20
$2.44
Portata 52W:
$0.95
$2.85
Aytu Biopharma Inc Stock (AYTU) Company Profile
Nome
Aytu Biopharma Inc
Settore
Telefono
(720) 437-6580
Indirizzo
7900 E. UNION AVENUE, DENVER
Confronta AYTU con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AYTU
Aytu Biopharma Inc
|
2.29 | 20.11M | 93.76M | -13.68M | 8.77M | -2.63 |
|
ZTS
Zoetis Inc
|
152.44 | 66.04B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 45.57B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.69 | 42.50B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.21 | 18.84B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
309.72 | 13.59B | 2.99B | 1.21B | 1.13B | 25.06 |
Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-01 | Iniziato | Lake Street | Buy |
| 2025-06-30 | Iniziato | Ascendiant Capital Markets | Buy |
| 2021-03-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-05-29 | Iniziato | H.C. Wainwright | Buy |
Aytu Biopharma Inc Borsa (AYTU) Ultime notizie
Aytu BioPharma Inc. stock daily chart insightsQuarterly Portfolio Review & Precise Trade Entry Recommendations - Newser
What machine learning models say about Aytu BioPharma Inc.July 2025 Analyst Calls & Weekly Chart Analysis and Trade Guides - Newser
Will Aytu BioPharma Inc. stock recover after recent dropLayoff News & Weekly Top Stock Performers List - Newser
Will Aytu BioPharma Inc. see short term momentumTrade Plan With Low Risk High Return - Newser
What recovery options are there for Aytu BioPharma Inc. [Earnings Risk Report]Verified Stock Trade Ideas - Newser
Can Aytu BioPharma Inc. benefit from deglobalizationFast ROI Stock Opportunities - thegnnews.com
Multi asset correlation models including Aytu BioPharma Inc.Free Daily Volume Spike Trading Signals - Newser
Combining price and volume data for Aytu BioPharma Inc.Free Weekly Watchlist of High Movers - Newser
How to recover losses in Aytu BioPharma Inc. stockDaily Technical Forecast for Quick Gains - Newser
Risk adjusted return profile for Aytu BioPharma Inc. analyzedFundamental Analysis for Value Stock Selection - Newser
What recovery options are there for Aytu BioPharma Inc.AI Short-Term Gain Forecast with Data - Newser
Why Aytu BioPharma Inc. stock attracts strong analyst attentionFree Consistent Profit Pattern Recognition Tools - Newser
What the charts say about Aytu BioPharma Inc. todayFree Access to Real-Time Trade Insights - Newser
Aytu BioPharma Inc. stock retracement – recovery analysisMarket Opportunity Tracker for Swing Traders - Newser
Live market analysis of Aytu BioPharma Inc.Support and Resistance Zone Summary Chart - Newser
How hedge fund analytics apply to Aytu BioPharma Inc. stockAI Powered Buy Point Forecast Planner - Newser
Full technical analysis of Aytu BioPharma Inc. stockGrowth Watchlist for Long Term Positioning - Newser
What makes Aytu BioPharma Inc. stock price move sharplyCapitalize on market shifts with expert advice - Jammu Links News
What are the latest earnings results for Aytu BioPharma Inc.Exceptional trading results - Jammu Links News
What are analysts’ price targets for Aytu BioPharma Inc. in the next 12 monthsInvest smarter with advanced market data - Jammu Links News
How does Aytu BioPharma Inc. compare to its industry peersGet real-time alerts on high-potential stocks - Jammu Links News
Does Aytu BioPharma Inc. stock perform well during market downturnsCapitalize on high-growth stocks early - Jammu Links News
Should I hold or sell Aytu BioPharma Inc. stock in 2025Capitalize on momentum-driven investment opportunities - Jammu Links News
Is it the right time to buy Aytu BioPharma Inc. stockInvest confidently with real-time data - Jammu Links News
What are Aytu BioPharma Inc. company’s key revenue driversSuperior investment outcomes - Jammu Links News
Is Aytu BioPharma Inc. a good long term investmentUnlock steady growth with low-risk stocks - Jammu Links News
Is Aytu BioPharma Inc. a growth stock or a value stockFree Real-Time Stock Data - Jammu Links News
Aytu BioPharma Inc. Stock Analysis and ForecastGet daily updates on top-performing stocks - Jammu Links News
When is Aytu BioPharma Inc. stock expected to show significant growthBuild wealth faster with professional insights - Jammu Links News
Evaluating Aytu BioPharma Inc. with trendline analysisPre-Market Stock Movement Summary and Review - Newser
Can trapped investors hope for a rebound in Aytu BioPharma Inc.Predictive System for Long-Term Stock Forecast - Newser
Should I buy Aytu BioPharma Inc. stock before earningsDaily Market Entry Strategy with Tools - Newser
Will Aytu BioPharma Inc. outperform the marketWeekly Portfolio Update with ROI Focus - Newser
Barclays Reiterates Sell Rating on Galapagos, Sets €22 Price Target - AInvest
Aytu Biopharma Inc Azioni (AYTU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Aytu Biopharma Inc Azioni (AYTU) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Disbrow Joshua R. | Chief Executive Officer |
Jun 09 '25 |
Buy |
1.50 |
66,666 |
99,999 |
153,257 |
| Disbrow Joshua R. | Chief Executive Officer |
Feb 28 '25 |
Buy |
1.30 |
15,000 |
19,500 |
86,591 |
4.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):